Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1773391 | 1.00 | MAPK1 (0.33) | MAPK1MEN1KMT2AHTTPOLB | |
| SCHEMBL756488 | 1.00 | MAPK1 (0.33) | MAPK1MEN1KMT2AHTTPOLB | |
| SCHEMBL756487 | 1.00 | MAPK1 (0.33) | MAPK1MEN1KMT2AHTTPOLB | |
| SCHEMBL11882807 | 0.83 | NPSR1 (0.33) | — | |
| SCHEMBL11878328 | 0.83 | NPSR1 (0.33) | — | |
| SCHEMBL11383093 | 0.83 | NPSR1 (0.33) | — | |
| SCHEMBL5432846 | 0.82 | AKT1 (0.30) | — | |
| SCHEMBL12451512 | 0.78 | HSD17B10 (0.30) | HSD17B10 | |
| SCHEMBL6557474 | 0.77 | — | — | |
| SCHEMBL2325064 | 0.76 | SLC1A2 (0.33) | HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| EP-3624762-B1 | PERFUMING COMPOSITIONS | GIVAUDAN SA (CH) | 2025-01-08 | — | — | EP | claimed |
| US-20240197221-A1 | FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-20240010954-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY | 2024-01-11 | — | — | US | claimed |
| WO-2023027037-A1 | MOLD MATERIAL FOR SHELL MOLDS | 旭有機材株式会社 | 2023-03-02 | — | — | WO | claimed |
| US-10918579-B2 | Density balanced high impact perfume microcapsules | FIRMENICH SA (CH) | 2021-02-16 | — | — | US | claimed |
| US-9200237-B2 | 4,8-dimethyl-4,9-decadienenitrile | KAO CORPORATION (JP) | 2015-12-01 | — | — | US | claimed |
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| EP-1737937-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2013-06-12 | — | — | EP | claimed |
| EP-2430140-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2012-03-21 | — | — | EP | claimed |
| EP-1737937-A2 | PERFUME COMPOSITIONS | Quest International Services B.V. (NL) | 2007-01-03 | — | — | EP | claimed |
| WO-2006095200-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2006-09-14 | — | — | WO | claimed |
| WO-2005103214-A2 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2005-11-03 | — | — | WO | claimed |
| US-20050160538-A1 | Fragance of 3-cis hexenol and ethanolamine to improve odor | KAO CORPORATION (JP) | 2005-07-28 | — | — | US | claimed |
| US-20050101799-A1 | Production process for high purity tricyclo-[5.2.1. 02,6]decane-2-carboxylic acid ester | KAO CORPORATION (JP) | 2005-05-12 | — | — | US | claimed |
| US-6780835-B2 | DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX | QUEST INTERNATIONAL B.V. (NL) | 2004-08-24 | — | — | US | claimed |
| EP-1021511-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | Bush Boake Allen Inc. (US) | 2000-07-26 | — | — | EP | claimed |
| WO-1999057233-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 1999-11-11 | — | — | WO | claimed |
| US-5972864-A | BLEACHING BLOCK; MIXTURE OF BLEACH AND ORGANOLEPTIC COMPOUND | LONZA INC. (US) | 1999-10-26 | — | — | US | claimed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101799-A1 | Production process for high purity tricyclo-[5.2.1. 02,6]decane-2-carboxylic acid ester | FFAR2, ELOVL1, DECR1 | MAPK1 2893/4885MEN1 4561/4885KMT2A 4460/4885 |
| US-20140227201-A1 | Antimicrobial Gel Formulations | CUTA, TUBA3C, POLR1C | MAPK1 4567/4885MEN1 2115/4885KMT2A 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.